Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × cixutumumab × Clear all

NCT00520481 2018-07-19

Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer

Phase 2 Completed

41 enrolled 14 charts

Prostatic Neoplasms

NCT00683475 2014-10-16

A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer

Phase 2 Completed

138 enrolled 17 charts

Prostatic Neoplasms